SGI
BLFS icon

Summit Global Investments’s BioLife Solutions BLFS Stock Holding History

Summit Global Investments’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-9,118
Closed -$228K – 540
2024
Q3 		$228K Buy
+9,118
New +$215K 0.01% 471

Other funds holding BLFS

CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
CRM
Cramer Rosenthal McGlynn Stamford, Connecticut $1.36B AUM 31.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Summit Global Investments's BLFS Position: Q4 2024 in Review

Summit Global Investments sold out of BioLife Solutions (BLFS) in Q4 2024, closing a stake of 9,118 shares — an estimated $228K sold.

Summit Global Investments first reported a position in BLFS in Q3 2024 and held it in 1 quarter. The position peaked at $228K in Q3 2024. 180 funds tracked by Wall St. Rank hold BLFS as of Q4 2024.

  • Summit Global Investments reported no remaining BioLife Solutions position as of Q4 2024 after selling out during the quarter.
  • Summit Global Investments sold 9,118 BioLife Solutions shares in Q4 2024, an estimated $228K.
  • Summit Global Investments first reported a position in BioLife Solutions in Q3 2024 and held it in 1 quarter.
  • Summit Global Investments's BioLife Solutions position peaked at $228K in Q3 2024.
  • 180 funds tracked by Wall St. Rank held BioLife Solutions as of Q4 2024.

Based on Summit Global Investments's 13F filing for Q4 2024, filed 11 Feb 2025.